In vitro screening of reversible and time-dependent inhibition on CYP3A by TM208 and TM209 in rat liver microsomes

TM208 and TM209, dithiocarbamate derivatives with potential anti-cancer effects, were evaluated in reversible and time-dependent cytochrome P450 (CYP) 3A inhibition assays in rat liver microsomes using testosterone as probe substrate. Both compounds were found to be weak reversible inhibitors and mo...

Full description

Bibliographic Details
Main Authors: Miaoran Ning, Liang Li, Jian Li, Zaiquan Li, Runtao Li, Tianyan Zhou, Wei Lu
Format: Article
Language:English
Published: Elsevier 2012-04-01
Series:Acta Pharmaceutica Sinica B
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383512000238
_version_ 1828324033230274560
author Miaoran Ning
Liang Li
Jian Li
Zaiquan Li
Runtao Li
Tianyan Zhou
Wei Lu
author_facet Miaoran Ning
Liang Li
Jian Li
Zaiquan Li
Runtao Li
Tianyan Zhou
Wei Lu
author_sort Miaoran Ning
collection DOAJ
description TM208 and TM209, dithiocarbamate derivatives with potential anti-cancer effects, were evaluated in reversible and time-dependent cytochrome P450 (CYP) 3A inhibition assays in rat liver microsomes using testosterone as probe substrate. Both compounds were found to be weak reversible inhibitors and moderate mechanism-based inhibitors of rat CYP3A. For reversible inhibition on rat CYP3A, the Ki values of competitive inhibition model were 12.10±1.75 and 13.94±1.31 μM, respectively. For time-dependent inhibition, the inactivation constants (Kl) were 31.93±12.64 and 32.91±15.58 μM, respectively, and the maximum inactivation rates (kinact) were 0.03497±0.0069 and 0.07259±0.0172 min−1 respectively. These findings would provide useful in vitro information for future in vivo DDI studies on TM208 or TM209.
first_indexed 2024-04-13T18:59:51Z
format Article
id doaj.art-0d723d23563344068ec9dc74e8a6cc28
institution Directory Open Access Journal
issn 2211-3835
2211-3843
language English
last_indexed 2024-04-13T18:59:51Z
publishDate 2012-04-01
publisher Elsevier
record_format Article
series Acta Pharmaceutica Sinica B
spelling doaj.art-0d723d23563344068ec9dc74e8a6cc282022-12-22T02:34:07ZengElsevierActa Pharmaceutica Sinica B2211-38352211-38432012-04-012218118710.1016/j.apsb.2012.02.006In vitro screening of reversible and time-dependent inhibition on CYP3A by TM208 and TM209 in rat liver microsomesMiaoran Ning0Liang Li1Jian Li2Zaiquan Li3Runtao Li4Tianyan Zhou5Wei Lu6Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, ChinaDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, ChinaDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, ChinaDepartment of Radiation Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, ChinaState Key Laboratory of Natural and Biomimetic Drugs (Peking University), Beijing 100191, ChinaState Key Laboratory of Natural and Biomimetic Drugs (Peking University), Beijing 100191, ChinaState Key Laboratory of Natural and Biomimetic Drugs (Peking University), Beijing 100191, ChinaTM208 and TM209, dithiocarbamate derivatives with potential anti-cancer effects, were evaluated in reversible and time-dependent cytochrome P450 (CYP) 3A inhibition assays in rat liver microsomes using testosterone as probe substrate. Both compounds were found to be weak reversible inhibitors and moderate mechanism-based inhibitors of rat CYP3A. For reversible inhibition on rat CYP3A, the Ki values of competitive inhibition model were 12.10±1.75 and 13.94±1.31 μM, respectively. For time-dependent inhibition, the inactivation constants (Kl) were 31.93±12.64 and 32.91±15.58 μM, respectively, and the maximum inactivation rates (kinact) were 0.03497±0.0069 and 0.07259±0.0172 min−1 respectively. These findings would provide useful in vitro information for future in vivo DDI studies on TM208 or TM209.http://www.sciencedirect.com/science/article/pii/S2211383512000238TM208TM209RLMsCYP3AReversible inhibitionTDIDDI
spellingShingle Miaoran Ning
Liang Li
Jian Li
Zaiquan Li
Runtao Li
Tianyan Zhou
Wei Lu
In vitro screening of reversible and time-dependent inhibition on CYP3A by TM208 and TM209 in rat liver microsomes
Acta Pharmaceutica Sinica B
TM208
TM209
RLMs
CYP3A
Reversible inhibition
TDI
DDI
title In vitro screening of reversible and time-dependent inhibition on CYP3A by TM208 and TM209 in rat liver microsomes
title_full In vitro screening of reversible and time-dependent inhibition on CYP3A by TM208 and TM209 in rat liver microsomes
title_fullStr In vitro screening of reversible and time-dependent inhibition on CYP3A by TM208 and TM209 in rat liver microsomes
title_full_unstemmed In vitro screening of reversible and time-dependent inhibition on CYP3A by TM208 and TM209 in rat liver microsomes
title_short In vitro screening of reversible and time-dependent inhibition on CYP3A by TM208 and TM209 in rat liver microsomes
title_sort in vitro screening of reversible and time dependent inhibition on cyp3a by tm208 and tm209 in rat liver microsomes
topic TM208
TM209
RLMs
CYP3A
Reversible inhibition
TDI
DDI
url http://www.sciencedirect.com/science/article/pii/S2211383512000238
work_keys_str_mv AT miaoranning invitroscreeningofreversibleandtimedependentinhibitiononcyp3abytm208andtm209inratlivermicrosomes
AT liangli invitroscreeningofreversibleandtimedependentinhibitiononcyp3abytm208andtm209inratlivermicrosomes
AT jianli invitroscreeningofreversibleandtimedependentinhibitiononcyp3abytm208andtm209inratlivermicrosomes
AT zaiquanli invitroscreeningofreversibleandtimedependentinhibitiononcyp3abytm208andtm209inratlivermicrosomes
AT runtaoli invitroscreeningofreversibleandtimedependentinhibitiononcyp3abytm208andtm209inratlivermicrosomes
AT tianyanzhou invitroscreeningofreversibleandtimedependentinhibitiononcyp3abytm208andtm209inratlivermicrosomes
AT weilu invitroscreeningofreversibleandtimedependentinhibitiononcyp3abytm208andtm209inratlivermicrosomes